Reversal of Direct Thrombin Inhibition After Cardiopulmonary Bypass in a Patient with Heparin-Induced Thrombocytopenia - Concepedia

Concepedia

Publication | Closed Access

Reversal of Direct Thrombin Inhibition After Cardiopulmonary Bypass in a Patient with Heparin-Induced Thrombocytopenia

75

Citations

31

References

2004

Year

Greg Stratmann, Anil DeSilva, Elaine Tseng, Julie Hambleton, Michel Balea, Anthony J. Romo, Michael J. Mann, Nancy Achorn, William Moskalik, Charles W. Hoopes

Anesthesia & Analgesia

Abstract

A combination of modified ultrafiltration, hemodialysis, and the administration of recombinant factor VIIa, fresh frozen plasma, and cryoprecipitate may reverse the anticoagulant effect of bivalirudin.

References

	Year	Citations
Blood-borne tissue factor: Another view of thrombosis Peter L.A. Giesen, Ursula Rauch, Bernd Bohrmann, Proceedings of the National Academy of Sciences	1999	974
Temporal Aspects of Heparin-Induced Thrombocytopenia Theodore E. Warkentin, J. G. Kelton New England Journal of Medicine	2001	967
Platelet activity of high‐dose factor VIIa is independent of tissue factor Dougald M. Monroe, Maureane Hoffman, Julie A. Oliver, British Journal of Haematology	1997	538
The Pharmacokinetics and Pharmacodynamics of Argatroban: Effects of Age, Gender, and Hepatic or Renal Dysfunction Suzanne K. Swan, Marcie J. Hursting Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy	2000	371
Effect of the administration of recombinant activated factor VII (rFVIIa; NovoSeven®) in the management of severe uncontrolled bleeding in patients undergoing heart valve replacement surgery M. Al Douri, Tariq Shafi, D. Al Khudairi, Blood Coagulation & Fibrinolysis	2000	174
An Effective Treatment of Severe Intractable Bleeding After Valve Repair by One Single Dose of Activated Recombinant Factor VII Herman G. D. Hendriks, Joost M. van der Maaten, Joost de Wolf, Anesthesia & Analgesia	2001	145
Blood Coagulation, Fibrinolytic, and Inhibitory Proteins in End-Stage Renal Disease: Effect of Hemodialysis Nosratola D. Vaziri, Eileen C. Gonzales, J. Wang, American Journal of Kidney Diseases ThrombosisHemodialysisUrologyRenal DiseaseRenal Function	1994	127
Treatment of Excessive Bleeding in Jehovah's Witness Patients after Cardiac Surgery with Recombinant Factor VIIa (NovoSeven®) Kenichi A. Tanaka, Amr A. Waly, William A. Cooper, Anesthesiology Adult Cardiac SurgeryCardiac AnaesthesiaSurgeryThrombosisWitness Patients	2003	103
Monocyte tissue factor expression, cell activation, and thrombin formation during cardiopulmonary bypass: A clinical study Mats Ernofsson, Stefan Thelin, Agneta Siegbahn Journal of Thoracic and Cardiovascular Surgery InflammationThrombosisCell ActivationCardiovascular DiseaseImmunology	1997	101
Recombinant factor VIIa to treat bleeding after cardiac surgery in an infant Joseph D. Tobias, John W. Berkenbosch, Pierantonio Russo Pediatric Critical Care Medicine	2003	93

Page 1